Product And Geographic Information

12 Months Ended

Jan. 03, 2015

Geographic Areas, Revenues from External Customers and Long-Lived Assets [Abstract]

Product And Geographic Information

PRODUCT AND GEOGRAPHIC INFORMATION

Segment Information

On January 28, 2014, the Company announced further organizational changes to combine its Implantable Electronic Systems Division and Cardiovascular and Ablation Technologies Division, resulting in an integrated R&D organization and a consolidation of manufacturing and supply chain operations worldwide. The integration was conducted in a phased approach during 2014. The Company's continuing global realignment efforts are focused on streamlining its organization to improve productivity, reduce costs and leverage its scale to drive additional growth. During 2014, the Company changed the information regularly reviewed by its Chief Executive Officer, whom the Company has determined to be its Chief Operating Decision Maker, such that it now operates as a single operating segment and derives its revenues from six principal product categories.

The Company's six principal product categories are as follows: tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker (pacemaker) systems, atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring device and other vascular accessories), structural heart products (heart valve replacement and repair products and structural heart defect devices) and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders). The Company generates its revenues from the sale of products it develops, manufactures and distributes globally. The Company had no individual customer that represented 10 percent or more of its consolidated revenues during 2014, 2013 or 2012.

Product Information

The following table presents net sales from external customers for the Company's six principal product categories (in millions):

Net Sales	2014		2013		2012
ICD Systems	$	1,746	$	1,741	$	1,743
Pacemaker Systems	1,047		1,042		1,111
Atrial Fibrillation Products	1,044		957		898
Vascular Products	709		704		716
Structural Heart Products	639		631		612
Neuromodulation Products	437		426		423
Net sales	$	5,622	$	5,501	$	5,503

Geographic Information

The following table presents net sales by significant country based on customer location (in millions):

Net Sales	2014		2013		2012
United States	$	2,657	$	2,596	$	2,594
Japan	526		567		665
Other foreign countries	2,439		2,338		2,244
Net sales	$	5,622	$	5,501	$	5,503

The amounts for long-lived assets by significant country include net property, plant and equipment by physical location of the asset as follows (in millions):

Long-Lived Assets	January 3, 2015		December 28, 2013		December 29, 2012
United States	$	1,005	$	1,045	$	1,036
Other foreign countries	338		365		389
Total long-lived assets	$	1,343	$	1,410	$	1,425